Intrinsic Value of S&P & Nasdaq Contact Us

Viatris Inc. VTRS NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
38/100
1/7 Pass
SharesGrow Intrinsic Value
$52.56
+277.9%
Analyst Price Target
$15.25
+9.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Viatris Inc. (VTRS) has a negative trailing P/E of -4.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 5.7 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -22.56%, forward earnings yield 17.57%. PEG 0.47 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (60/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.47).
  • Forward P/E 5.7 — analysts expect a return to profitability with estimated EPS of $2.44 for FY2026.
  • PEG Ratio 0.47 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -22.56% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 17.57% as earnings recover.
  • Analyst consensus target $15.25 (+9.6% upside) — modest upside expected.

Overall SharesGrow Score: 38/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
38/100
SG Score
View full scorecard →
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
40/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
61/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — VTRS

Valuation Multiples
P/E (TTM)-4.4
Forward P/E5.7
PEG Ratio0.47
Forward PEG0.47
P/B Ratio1.06
P/S Ratio1.09
EV/EBITDA-73.1
Per Share Data
EPS (TTM)$-3.05
Forward EPS (Est.)$2.44
Book Value / Share$12.76
Revenue / Share$12.41
FCF / Share$1.58
Yields & Fair Value
Earnings Yield-22.56%
Forward Earnings Yield17.57%
Dividend Yield3.55%
SharesGrow IV$52.56 (+277.9%)
Analyst Target$15.25 (+9.6%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 41.4 -0.87 1.79 1.79 -
2017 32.5 0.85 1.70 1.90 -
2018 40.1 -0.86 1.16 1.24 -
2019 670.0 -7.03 0.95 0.98 -
2020 -16.8 0.00 0.49 0.94 -
2021 -12.9 2.38 0.80 0.91 2.44%
2022 6.5 -0.02 0.64 0.83 4.31%
2023 237.6 -2.44 0.64 0.84 4.43%
2024 -23.4 0.02 0.80 1.01 3.87%
2025 -4.1 -0.01 0.99 1.02 3.85%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.92 $11.08B $480M 4.3%
2017 $1.30 $11.91B $696M 5.8%
2018 $0.68 $11.43B $352.5M 3.1%
2019 $0.03 $11.5B $16.8M 0.1%
2020 $-1.11 $11.95B $-669.9M -5.6%
2021 $-1.05 $17.89B $-1.27B -7.1%
2022 $1.71 $16.26B $2.08B 12.8%
2023 $0.05 $15.43B $54.7M 0.4%
2024 $-0.53 $14.74B $-634.2M -4.3%
2025 $-3.00 $14.3B $-3.51B -24.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $2.44 $2.40 – $2.49 $14.62B $14.26B – $14.79B 6
2027 $2.66 $2.32 – $2.79 $14.89B $14.8B – $15.01B 6
2028 $3.08 $1.41 – $4.75 $15.15B $15.07B – $15.22B 2
2029 $0.00 $0.00 – $0.00 $14.97B $14.78B – $15.11B 0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message